financetom
Business
financetom
/
Business
/
Trinity Investments and Certares Announce Sale of EAST Miami to Blackstone Real Estate
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trinity Investments and Certares Announce Sale of EAST Miami to Blackstone Real Estate
Sep 10, 2025 6:59 AM

MIAMI--(BUSINESS WIRE)--

Funds managed by Trinity Investments (“Trinity”), a private real estate investment firm specializing in hotels and hospitality, and funds managed by Certares Real Estate Management LLC (“Certares”), today announced the sale of EAST Miami, a 352-room lifestyle hotel, to funds affiliated with Blackstone Real Estate.

Opened in 2016, EAST Miami anchors Brickell City Centre, the landmark $1.1 billion luxury retail, residential and hospitality center in the heart of Miami’s Brickell neighborhood. In addition to its modern guestrooms and 89 serviced apartments, EAST Miami is known for its popular dining venues, including Sugar, the rooftop bar that has become one of Miami’s top nightlife destinations.

Trinity and Certares acquired EAST Miami in 2021 from Swire Properties. Since then, the ownership group has focused on operational improvements and driving revenue growth while building a strong partnership with Swire Hotels – the original developer and a relatively new entrant to the U.S. market with its EAST hotel brand. This collaboration helped optimize performance and contributed to record financial results, including a more than 60% increase in net operating income during the first full year of ownership.

“EAST Miami is a great example of how hands-on ownership and strategic partnerships can create meaningful value,” said Sean Hehir, Managing Partner, President, and CEO of Trinity Investments. “This transaction also marks the first fully realized asset by Trinity GP Fund I L.P., underscoring our ability to identify and enhance high-quality hotels in key markets.”

“This transaction demonstrates how we at Certares use our deep travel and hospitality expertise, as well as our proprietary data and market insights, to identify neighborhoods and assets that are poised for growth,” said Nolan Hecht, Senior Managing Director and Head of Real Estate at Certares. “With focused management and strategic capital deployment, we have helped EAST Miami become a truly world-class destination, and we look forward to watching the hotel’s positive trajectory continue under Blackstone’s experienced stewardship.”

Scott Trebilco, Senior Managing Director at Blackstone Real Estate, said: "The acquisition of this luxury hotel located in one of the most dynamic areas of Miami reflects our strong conviction in travel and hospitality. The Brickell neighborhood is experiencing a rapid transformation with strong employment and population growth, as well as exciting leisure attractions and entertainment events, creating a compelling backdrop for the property.”

The sale comes on the heels of Trinity and Certares’ successful recapitalization of the Hyatt Regency Greenwich. Together, the firms continue to focus on identifying opportunities to enhance hotel performance and deliver strong results for investors.

Terms of the transaction were not disclosed.

About Trinity Investments

Trinity is a private real estate investment firm with a 29-year history of specializing in value-add opportunities. Based in Miami, with offices in Honolulu, Los Angeles, and London, Trinity focuses on unique real estate investments in world-class markets. As of June 2025, Trinity has invested more than $10 billion in the United States, Mexico, Europe, and Japan by leveraging its deep institutional knowledge and longstanding local relationships. For additional information, please visit Trinity’s website at www.trinityinvestments.com. For updates on Trinity’s investment activity, follow Trinity on LinkedIn.

About Certares

Established in 2012, Certares is a global investment firm focused exclusively on the travel and hospitality industries, leveraging deep sector experience, proprietary transactions, and hands-on partnership with management teams to drive growth. With approximately $7 billion of assets under management, including co-investments, as of December 31, 2024, Certares brings together a team with decades of both operational and investment experience in private equity, travel, tourism, hospitality and travel-related business and consumer services. Since launching its real estate platform in early 2021, Certares has acquired 16 hotels, comprising over 3,700 keys across the country. For more information, please visit www.certares.com.

Source: Trinity Investments

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cava Group Insider Sold Shares Worth $222,512,803, According to a Recent SEC Filing
Cava Group Insider Sold Shares Worth $222,512,803, According to a Recent SEC Filing
Jun 7, 2024
04:07 PM EDT, 06/07/2024 (MT Newswires) -- Ronald M Shaich, Director, on June 05, 2024, sold 2,550,290 shares in Cava Group ( CAVA ) for $222,512,803. Following the Form 4 filing with the SEC, Shaich has control over a total of 7,149,899 shares of the company, with 5,000 shares held directly and 7,144,899 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1639438/000162828024027251/xslF345X03/wk-form4_1717790405.xml Price: 85.00,...
Cytokinetics Insider Sold Shares Worth $1,099,125, According to a Recent SEC Filing
Cytokinetics Insider Sold Shares Worth $1,099,125, According to a Recent SEC Filing
Jun 7, 2024
04:06 PM EDT, 06/07/2024 (MT Newswires) -- Robert I Blum, Director, President & CEO, on June 04, 2024, sold 22,500 shares in Cytokinetics ( CYTK ) for $1,099,125. Following the Form 4 filing with the SEC, Blum has control over a total of 443,311 shares of the company, with 439,145 shares held directly and 4,166 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1061983/000112760224018143/xslF345X03/form4.xml...
Blueprint Medicines Insider Sold Shares Worth $420,520, According to a Recent SEC Filing
Blueprint Medicines Insider Sold Shares Worth $420,520, According to a Recent SEC Filing
Jun 7, 2024
04:07 PM EDT, 06/07/2024 (MT Newswires) -- Percy H. Carter, Chief Scientific Officer, on June 05, 2024, sold 4,000 shares in Blueprint Medicines ( BPMC ) for $420,520. Following the Form 4 filing with the SEC, Carter has control over a total of 41,895 shares of the company, with 41,895 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1597264/000141588924015943/xslF345X03/form4-06072024_040602.xml ...
Recursion Pharmaceuticals Insider Sold Shares Worth $871,000, According to a Recent SEC Filing
Recursion Pharmaceuticals Insider Sold Shares Worth $871,000, According to a Recent SEC Filing
Jun 7, 2024
04:07 PM EDT, 06/07/2024 (MT Newswires) -- Christopher Gibson, Director, Chief Executive Officer, on June 05, 2024, sold 100,000 shares in Recursion Pharmaceuticals ( RXRX ) for $871,000. Following the Form 4 filing with the SEC, Gibson has control over a total of 708,738 shares of the company, with 708,738 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1601830/000160183024000077/xslF345X03/wk-form4_1717790504.xml Price: 8.60, Change: +0.09,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved